Marker Therapeutics, Inc. (MRKR)

Marker Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	19.19	15.11	11.78	42.35	21.35
Cash & Short-Term Investments	19.19	15.11	11.78	42.35	21.35
Cash Growth	27.01%	28.26%	-72.18%	98.34%	-51.37%
Other Receivables	2.35	1.03	2.4	0	1
Receivables	2.35	1.03	2.4	0	1
Prepaid Expenses	0.48	0.99	1.85	2.48	2.06
Restricted Cash	-	-	-	1.15	-
Other Current Assets	-	-	0.59	-	-
Total Current Assets	22.02	17.13	16.62	45.98	24.41
Property, Plant & Equipment	-	-	-	22.15	21.2
Other Long-Term Assets	-	-	17.8	-	-
Total Assets	22.02	17.13	34.42	68.14	45.61
Accounts Payable	1.07	0.96	1.1	5.14	2.94
Accrued Expenses	2.19	1.91	1.27	3.33	2.95
Current Portion of Leases	-	-	-	0.62	0.39
Current Unearned Revenue	-	-	-	1.15	-
Other Current Liabilities	0.2	0.21	5.41	2.66	0.13
Total Current Liabilities	3.46	3.07	7.78	12.9	6.4
Long-Term Leases	-	-	-	11.25	11.87
Other Long-Term Liabilities	-	-	7.04	-	-
Total Liabilities	3.46	3.07	14.82	24.15	18.27
Common Stock	0.01	0.01	0.01	0.01	0.05
Additional Paid-In Capital	465.56	450.33	447.64	442.1	383.53
Retained Earnings	-447.02	-436.29	-428.05	-398.12	-356.24
Shareholders' Equity	18.56	14.05	19.6	43.99	27.34
Total Liabilities & Equity	22.02	17.13	34.42	68.14	45.61
Total Debt	-	-	-	11.87	12.26
Net Cash (Debt)	19.19	15.11	11.78	30.48	9.1
Net Cash Growth	27.01%	28.26%	-61.35%	235.15%	-79.05%
Net Cash Per Share	2.14	1.72	1.41	3.98	1.93
Filing Date Shares Outstanding	10.71	8.9	8.8	8.31	5.07
Total Common Shares Outstanding	10.71	8.89	8.41	8.31	5.07
Working Capital	18.56	14.05	8.84	33.08	18.01
Book Value Per Share	1.73	1.58	2.33	5.29	5.39
Tangible Book Value	18.56	14.05	19.6	43.99	27.34
Tangible Book Value Per Share	1.73	1.58	2.33	5.29	5.39
Machinery	-	-	-	9.66	3.87
Construction In Progress	-	-	-	2.23	6.79
Leasehold Improvements	-	-	-	3.17	0.29

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q